Andrews Sykes (ASY), a 380p offer price November share tip, has announced results for the 2016 calendar year and that it is “cautiously optimistic for further success in 2017”…
Marcus Stuttard, head of AIM and the oxymorons of AIM Regulation, had a specially selected and beautifully diversified portfolio of AIM stocks chosen by ShareProphets back at the end of last September so that he could demonstrate his faith in the regulatory set-up of the market he runs. Naturally, there was nothing at all wrong with any of the companies picked: they were all trading on the Casino as normal, so we were just plain wrong to be Red Flagging them all for one reason or another. We were just so, so wrong that……
I asked my very good pals at the Financial Reporting Council, who we know are major fans of my work, to look into the fraudulent accounts of Eden Research (EDEN) for 2011, 2012, 2013, 2014 and 2015 on February 17 2016. Okay 2015 accounts were not out at that point but I was sure they would be fraudulent - they were. Now 2016 accounts for Terpenetech are out we have it again confirmed that the 2015 accounts were crook and 2016 accounts - due within days - will almost certainly be fraudulent. So I have written to the FRC again. The letter follows.
There were spectacular gains in gold and silver last year and that has affected people’s expectations since most of those gains have now been given up. In the near term we will likely test support at $16 silver and $1200 for gold - that is the warning from gold guru Brad Cooke. But... The Fed has set a course of quarterly rate increases that is faster than economic growth which is a formula for stagflation and recession, when this happens investors holding gold and silver investments will do well.
Well, the first non-Tom article is by me, at a lofty #4: Leavers are either nuts or hiding what they're really on about. There, I said it. To be honest, I still haven't received a satisfying answer in the comments.
Despite the nonsense spouted by AberdeenMan, Mr Selfridge and BrokerMan1 on LSE about CloudTag (CTAG) and its bright prospects, confirmation that the end is nigh has reached Companies House with the CEO, Amit Ben-Haim, stepping off the board of CloudTag’s UK subsidiary and being replaced by the Grim Reaper himself, Massimo Ventimiglia.
The issue with Genoma was flagged up in the interims pre-Christmas. It owes Premaitha (NIPT) £750,000. That debt looks like a bad debt because the Swiss company has - despite its parent company concluding a fundraise - been having financial issues. So Premaitha has gone to court and had Genoma made bankrupt.
There were many fine entries for the Jezza caption contest, but there can only be one winner.
We are now way ahead on this share tip which was at a 6.75p offer. The shares are now 15.25p-16p on the back of a very bullish trading statement. But before you think about taking profits on Symphony Environmental (SYM) remember that the market cap is still just £23.6 million.
I spend most of my time being critical of companies that issue RNS’s containing half-truths, exaggerations or are just an opaque mess. However, a week ago, I read an RNS which impressed me for being just the opposite. It persuaded me to do further research which has led to this very rare beast – a buy tip….for Frontier Smart Technologies (FST).
From the FCA's spreadsheet of short positions required to be disclosed to it, the following shows the shorted AIM shares with positions from 2016 and thus far in 2017 (by net short position %) - and if this position has increased (red), reduced (green) or remained unchanged (black) since last week...
Stanley Gibbons (SGI) “is pleased to announce the sale of a major part of its Interiors division and to provide an update on its current trading and the restructuring”…
Hello Share Pinkers. As the markets are closed, I thought I might do a weekend piece to encourage you to carry on trading once the doors open again. We are constantly reminded on this legendary website that shares are overvalued and about to crumble. I don’t doubt it, though I’m fairly convinced the bull run has some months to go yet.
Following boardroom change, BowLeven (BLVN) “is pleased to announce an update on progress with the company's strategic efficiency programme and on the current status of its existing assets. The company also announces the adoption of a Transformation Incentive Plan designed to align employees' interests with the company's longer term strategic objectives”. Hmmm…
I last wrote on leading esports business, Gfinity, in July last year following its placing at 5p when it looked as if, potentially, the game was on. Having just announced a £6.25 million placing at 20p this morning, it is now certainly all to play for. It is worth applauding a few involved here but I still have a couple of reservations / observations.
Petropavlovsk (POG) has announced that it has received notification that three shareholders will vote against the re-election of all five existing directors and attempt to insert four new chaps at the forthcoming EGM. The shareholders all got their holding via the debt for equity swap and so are well in the money and are Renova Asset Holding Limited, Sothic Capital European Opportunities Master Fund Limited and M&G Debt Opportunities Fund II Limited.
Greetings, my friend. We are all interested in the future, for that is where you and I are going to spend the rest of our lives. And remember, my friend, future events such as these will affect you in the future. So caption this future picture of future Prime Minister Jezza Corbyn. Deadline is midnight tonight.
Shares in electronics products for the wireless telecoms infrastructure and related markets-focused, Filtronic (FTC) are currently the highest risers of the day. This on the back of a “Trading Update” announcement…
Shares in Optibiotix (OPTI) hit 60.5p mid at one point Wednesday but closed at 61p-63p. Having retipped this as a buy in the low seventies and at up to 80p we have received a number of emails saying "should we sell?" Some were citing savants on the LSE Bulletin Board who make dire predictions and others were asking what is wrong?
Under its Bracknor death-spiral funding package, AIM-listed Advanced Oncotherapy (AVO) has to call an EGM proposing resolutions to drop the current nominal, or “par”, 25p price of its shares by at least half in the event of 10 consecutive closes below 110% of nominal (ie below 27.5p). But the company has never defined the closing price used: is it mid-price, bid-price, offer-price at close, or perhaps some more convoluted closing daily VWAP (volume weighted average price) calculation? But one thing is for sure, the match is right next to the blue touch-paper. Is it today or Monday, fellas?
The May edition of the UK Investor Show Magazine is live featuring three share tips from Gary Newman, the Greek meltown is worse than everyone thinks, and the EU is not fit for purpose plus a photofeature from the 2017 UK Investor Show.
The busting of a placing by AIM-listed UK Oil and Gas (UKOG) at 1p by Tom Winnifrith has caused a bit of controversy. It is not the first time he has been accused of being irresponsible by blowing the lid on a placing only for it to be pulled or the price dropped. Anyone left holding the baby gets their fingers burned – in the recent example quite badly if they had been buying into the ramp at north of 1.4p only to see the company raise cash at just 0.8p. Is it right?
The nauseating Mail on Sunday fawned upon Pippa Middleton and her ghastly family as they celebrated the "wedding of the Year". Bring on the revolution! But perhaps the real wedding of the year should be between our two very own in-house Bulletin Board Morons GrannySnuffs & Wildes who seem made for each other. can you find examples on the LSE Asylum, iii, ADVFN or twitter of comments more idiotic than those of our own dream team? If so post in the comments section below, the deadline is midnight Sunday 28th May.
Having bought itself some time by declaring an initial sack-the-board General Meeting requisition “invalid” (a revised, valid requisition announced by it at an attempted ‘no one watching o’clock’, 5:15 pm, on Friday), Infrastrata (INFA) has this afternoon made a “Review of stategic options & project update” announcement...
AIM-listed travel agent and wannabe Greek holiday resort developer Minoan (MIN) announced a small bolt-on acquisition this morning….and a placing. Oh, and an update on its debt facility due to expire at the end of June. It is disappointing to see a placing (at 9p), but in the general scheme of things it is a relatively small amount so the pill is sugared to some extent.
It was a keen competition this week. But we have found a winner.
Take a look! European investors are clearly failing to grasp the very significant financial and commercial benefits available for Orphan or Rare Disease drug developers. So much so in fact, that sector-focussed Amryt Pharma (AMYT) finds no quoted peers in London, yet a good basket of NASDAQ-listed comparables are seen to command a significant premium despite mostly being pre-revenue and somewhat earlier in their development. Such anomalies can and, of course, do rapidly correct.
Any reader of my pieces will know I hold Challenger Acquisitions (CHAL) in pretty low regard but the outrageous ramping that has now gone on for the last four trading days is an absolute disgrace and the FCA should take a look. I’ll explain.
I have already covered the dire financials of Eden Research that indicate it is just months from trading whilst insolvent as well as its panning by the Financial Reporting Council (FRC) - in response to my urgings. Now to today's monstrous half truths - I am perhaps being 50% too charitable in that description.
Eden Research (EDEN) has today published godawful results and admitted that my very good friends at the Financial Reporting Council (FRC) investigated it - after I requested such an investigation - and have forced it to restate past numbers. It claims that the FRC has now settled all matters. Au contraire. that is another lie from the fraudsters and there are many more porkies in this statement. Truly, the pants of shamed PR Paul Queenie McManus of Walbrook will be cinders and ash after this effort. This all came out as Eden published Godawful numbers for calendar 2016.
The sold-out success that was the 1st April 2017 UK Investor Show again saw five 'Dragon's Den' sessions where a number of CEOs each gave a pitch and three Dragons each picked one stock for a £1,000 investment. How are they faring so far?...
With some great investigative journalism of which this website would have been proud, Brokerman Dan flushed it out a few weeks ago. The former bank robber - correctly - stated that Andalas (ADL) was looking to raise £1 million at 0.06p and the AIM listed crock of shit suspended its shares. Today they are unsuspended after the company raised £600,000 at 0.1p. It says this is at a premium to the suspension price. But it is a spoof, Andalas is still bust. It is insolvent as of today!
Malcolm Stacey is old enough to know about King Canute. In fact he is so old that he was there as a boy when the King sat in his chair on the beach and attempted to turn back the tide. Malcolm surely you remember the day as if it was yesterday? In which case why do you forget this valuable lesson when it comes to Inmarsat (ISAT) and your article today in which you misquote me and get it wrong in so many other ways.
"A credit crunch is brewing and when it happens, the UK is going to get hurt." These are not my words but the start of the Editorial in this weekend’s Guardian. The article then went on to say "That is the message emerging from senior executives in the financial services industry, who do not think Britain has changed that much since the 2008 credit disaster and the devastating crash that followed. Three developments lie at the heart of this disturbing analysis: spectacular growth in the sale of second mortgages, car loans and credit cards." I would heartily agree with these comments as this is my experience too. But what the article fails to say is that the UK is not alone in this debt bubble - once more it is a Global issue.
Hello Share Scoopers. There have been quite a few occasions now that I’ve commended a Footsie satellite company to your attention. On each mention, as I recall, the share grew in value. However, last year the shares took a big knock.
One of the most fascinating scenes I’ve seen for some time is the sight of Big Donald jigging around with some sort of weird entertainment put on by the Saudi’s for the President's visit. It almost made me forget the big benefit of this amiable state visit on share shifters like us. And that of course is that the President’s friendly reception sent the oil price up.
An announcement from Corero Network Security (CNS) with a headline “Corero Tier 1 Internet service provider customer GTT Communications, Inc. launches DDoS Mitigation service”. Then “further to the announcement on 19 April 2017 regarding a Global Tier 1 Internet service provider customer win… announces that the customer, GTT Communications, Inc. (NYSE: GTT), has launched its DDoS Mitigation service”. “Global Tier 1” now hey! And you what? The contract win has already been announced? Ramptastic…
Together Robert Sutherland Smith and Tom Winnifrith have now been working in finance for 71 years - the last ten or so together. Tom wishes to stress that RSS accounts for most of that, the great value investor starting his City career at the Unilever Pension Fund the year before Tom was born. In this book they outline 71 tricks of the trade for making money from shares.
Get the first ShareProphets Pocket Guide ebook, EIS - Buying shares with numerous tax breaks. Want to cut your income tax bill, get loss relief if your AIM listed shares go down, pay no CGT, avoid IHT - EIS could be the way and this book explains how.
Most investment books seem to be large enough to keep the front door open and while some contain gems it is hard to find them amid the verbiage. The aim here is to produce a short guide which simply cuts to the chase. I hope that it will provide food for thought for everyone from beginner to expert but whoever you are it should be quick and easy to read and digest.
Search ShareProphets |
Stock market news |
Recent Comments |